Natarajan Muthusamy
Affiliations: | Ohio State University, Columbus, Columbus, OH |
Area:
Cell BiologyGoogle:
"Natarajan Muthusamy"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Long M, Wang L, Leach V, et al. (2023) A CD3 humanized mouse model unmasked unique features of T-cell responses to bispecific antibody treatment. Blood Advances |
| Chan WK, Williams J, Sorathia K, et al. (2023) A novel CAR-T cell product targeting CD74 is an effective therapeutic approach in preclinical mantle cell lymphoma models. Experimental Hematology & Oncology. 12: 79 |
| Sircar A, Singh S, Xu-Monette ZY, et al. (2023) Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma. Leukemia |
| Yano M, Byrd JC, Muthusamy N. (2022) Natural Killer Cells in Chronic Lymphocytic Leukemia: Functional Impairment and Therapeutic Potential. Cancers. 14 |
| Chiang CL, Hu EY, Chang L, et al. (2022) Leukemia-initiating HSCs in chronic lymphocytic leukemia reveal clonal leukemogenesis and differential drug sensitivity. Cell Reports. 40: 111115 |
| Yano M, Sharpe C, Lance JR, et al. (2022) Evaluation of allogeneic and autologous membrane-bound IL-21-expanded NK cells for chronic lymphocytic leukemia therapy. Blood Advances |
| Collard JP, McKenna MK, Noothi SK, et al. (2022) Role of the splenic microenvironment in chronic lymphocytic leukemia development in Eµ-TCL1 transgenic mice. Leukemia & Lymphoma. 1-13 |
| Hu EY, Do P, Goswami S, et al. (2021) The ROR1 antibody-drug conjugate huXBR1-402-G5-PNU effectively targets ROR1+ leukemia. Blood Advances. 5: 3152-3162 |
| Rivas JR, Liu Y, Alhakeem SS, et al. (2021) Interleukin-10 suppression enhances T-cell antitumor immunity and responses to checkpoint blockade in chronic lymphocytic leukemia. Leukemia |
| Hu EY, Blachly JS, Saygin C, et al. (2020) LC-FACSeq is a method for detecting rare clones in leukemia. Jci Insight. 5 |